← Back to patent-cliff list
蔗糖氢氧化氧铁
Tier C — Watch / tradeSucroferric Oxyhydroxide
Vifor Fresenius Medical Care Renal Pharma France
Originator
2013
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：Not applicable
Brand：ピートル顆粒分包、Ferrum Hausmann 100 mg iron、Velphoro、维福瑞、ピートルチュアブル錠、P-TOL、VELPHORO
Indications (approved)：高磷血症
Regional status
US
批准上市
2013-11-27
EU
批准上市
2014-08-26
China
批准上市
2023-02-21
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Sucroferric Oxyhydroxide?
Approved indications include: 高磷血症.
When does the Sucroferric Oxyhydroxide patent expire?
No public expiry year is available for Sucroferric Oxyhydroxide yet; this page updates once verified.
How do I get a quote for Sucroferric Oxyhydroxide intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-24